Virtual and Augmented Reality in Healthcare Market By Component (Hardware, Software, Services) , By Technology (Augmented Reality, Virtual Reality) By End User (Hospitals, Research Institutions, Diagnostic Centers, Clinics) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The virtual and augmented reality in healthcare market was valued at $2.5 billion in 2023, and is projected t%li%reach $14.9 billion by 2033, growing at a CAGR of 19.6% from 2024 t%li%2033.
Augmented reality (AR) and virtual reality (VR) serve as practical tools in modern medical practices. AR facilitates the accumulation of data, which is subsequently represented as 3D model, whereas VR is used for recreation of the environment virtually. These technologies are revolutionizing the processes such as surgical simulations, patient care, remote consultation, and medical training.
The growth of the virtual and augmented reality in healthcare market is majorly driven by increase in demand for AR and VR in healthcare t%li%improve imaging methods, patient treatment programs, and surgical training. In addition, alarming increase in the prevalence of chronic diseases necessitates innovative treatment and management solutions, which VR and AR can provide through remote monitoring, rehabilitation, and patient education, thereby contributing toward the growth of the market. Moreover, surge in demand for better training tools drives the adoption of VR and AR for realistic simulations, allowing medical students and professionals t%li%practice procedures in a safe, controlled environment. The planning and performance of intricate surgical procedures, as well as the training of medical professionals, are greatly improved by immersive and interactive settings of these technologies. Surgeons may practice procedures in 3D settings created by VR that are realistic and immersive, all without putting patients at danger. Surgeons can improve their skills and decision-making processes by using these simulators, which can recreate a variety of circumstances, including uncommon and challenging instances. For instance, in 2022, with the assistance of VR-enabled surgical procedure, a pair of conjoined twins, Bernard%li%and Arthur Lima—three-year-olds from Brazil—were successfully separated. As these twins were born joint at the head with their brains interconnected, medical experts were of the opinion that it was impossible t%li%separate them and ensure there was n%li%loss of life. However, the surgery was accomplished successfully with the help of VR technology in a hospital in Ri%li%de Janeir%li%that was directed live by Dr. Noor ul Owase Jeelani from a hospital in London. This extraordinary surgical intervention stands as a benchmark in enhancing surgical precision and patient outcomes. However, high expense of the gadget and the requirement for a lot of processing power limit the adoption of AR and VR. Moreover, concerns associated with user satisfaction and safety significantly hamper the market growth. Around 65% of the respondents have experienced concerns about comfort, usability, and the immersive nature of AR and VR devices, indicating these as the most common barriers faced among users. Thus, improving the practicality and usability of these technologies is essential for their wider acceptance. In addition, about 27% of the respondents mentioned about the cost t%li%consumers. On the contrary, rise in investments from venture capitalists, government grants, and private sectors in VR and AR healthcare start-ups and research initiatives is expected t%li%offer remunerative opportunities for the expansion of the market during the forecast period. Moreover, continuous improvements in VR and AR hardware and software, such as better graphics, more powerful processors, and advanced sensors, will make these technologies more effective and accessible, thus opening new avenues for the expansion of the global market.
The VR and AR in healthcare industry is segmented int%li%component, technology, end user, and region. By component, the market is divided int%li%hardware, software, and services. On the basis of technology, it is categorized int%li%augmented reality and virtual reality. Depending on end user, it is classified int%li%hospitals, research institutions, diagnostic centers, and clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By component, the hardware segment dominated the market share in 2023.
On the basis of technology, the augmented reality segment was the major shareholder in 2023.
Depending on end user, the hospitals segment acquired the largest market share in 2023.
Region wise, North America held a dominant position in the market in 2023; however, Asia-Pacific is expected t%li%register the highest CAGR during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global Virtual and Augmented Reality in Healthcare Market include CAE, GE Healthcare, Koninklijke Philips N.V., Intuitive Surgical, Inc., Siemens Ltd., Eon Reality, Inc, Bioflight VR, WorldViz, TheraSim Inc, and MindMaze. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%gain a strong foothold and sustain the intense competition.
Additional benefits you will get with this purchase are:
By Component
Augmented reality (AR) and virtual reality (VR) serve as practical tools in modern medical practices. AR facilitates the accumulation of data, which is subsequently represented as 3D model, whereas VR is used for recreation of the environment virtually. These technologies are revolutionizing the processes such as surgical simulations, patient care, remote consultation, and medical training.
The growth of the virtual and augmented reality in healthcare market is majorly driven by increase in demand for AR and VR in healthcare t%li%improve imaging methods, patient treatment programs, and surgical training. In addition, alarming increase in the prevalence of chronic diseases necessitates innovative treatment and management solutions, which VR and AR can provide through remote monitoring, rehabilitation, and patient education, thereby contributing toward the growth of the market. Moreover, surge in demand for better training tools drives the adoption of VR and AR for realistic simulations, allowing medical students and professionals t%li%practice procedures in a safe, controlled environment. The planning and performance of intricate surgical procedures, as well as the training of medical professionals, are greatly improved by immersive and interactive settings of these technologies. Surgeons may practice procedures in 3D settings created by VR that are realistic and immersive, all without putting patients at danger. Surgeons can improve their skills and decision-making processes by using these simulators, which can recreate a variety of circumstances, including uncommon and challenging instances. For instance, in 2022, with the assistance of VR-enabled surgical procedure, a pair of conjoined twins, Bernard%li%and Arthur Lima—three-year-olds from Brazil—were successfully separated. As these twins were born joint at the head with their brains interconnected, medical experts were of the opinion that it was impossible t%li%separate them and ensure there was n%li%loss of life. However, the surgery was accomplished successfully with the help of VR technology in a hospital in Ri%li%de Janeir%li%that was directed live by Dr. Noor ul Owase Jeelani from a hospital in London. This extraordinary surgical intervention stands as a benchmark in enhancing surgical precision and patient outcomes. However, high expense of the gadget and the requirement for a lot of processing power limit the adoption of AR and VR. Moreover, concerns associated with user satisfaction and safety significantly hamper the market growth. Around 65% of the respondents have experienced concerns about comfort, usability, and the immersive nature of AR and VR devices, indicating these as the most common barriers faced among users. Thus, improving the practicality and usability of these technologies is essential for their wider acceptance. In addition, about 27% of the respondents mentioned about the cost t%li%consumers. On the contrary, rise in investments from venture capitalists, government grants, and private sectors in VR and AR healthcare start-ups and research initiatives is expected t%li%offer remunerative opportunities for the expansion of the market during the forecast period. Moreover, continuous improvements in VR and AR hardware and software, such as better graphics, more powerful processors, and advanced sensors, will make these technologies more effective and accessible, thus opening new avenues for the expansion of the global market.
The VR and AR in healthcare industry is segmented int%li%component, technology, end user, and region. By component, the market is divided int%li%hardware, software, and services. On the basis of technology, it is categorized int%li%augmented reality and virtual reality. Depending on end user, it is classified int%li%hospitals, research institutions, diagnostic centers, and clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By component, the hardware segment dominated the market share in 2023.
On the basis of technology, the augmented reality segment was the major shareholder in 2023.
Depending on end user, the hospitals segment acquired the largest market share in 2023.
Region wise, North America held a dominant position in the market in 2023; however, Asia-Pacific is expected t%li%register the highest CAGR during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global Virtual and Augmented Reality in Healthcare Market include CAE, GE Healthcare, Koninklijke Philips N.V., Intuitive Surgical, Inc., Siemens Ltd., Eon Reality, Inc, Bioflight VR, WorldViz, TheraSim Inc, and MindMaze. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%gain a strong foothold and sustain the intense competition.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
By Component
- Hardware
- Software
- Services
- Augmented Reality
- Virtual Reality
- Hospitals
- Research Institutions
- Diagnostic Centers
- Clinics
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- CAE
- GE Healthcare
- Koninklijke Philips N.V.
- Intuitive Surgical, Inc.
- Siemens Ltd
- Eon Reality, Inc
- Bioflight VR
- WorldViz
- TheraSim Inc
- MindMaze
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ASSISTIVE DEVICES FOR VULNERABLE GROUPS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Hearing Vision Aids
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Mobility Assistive Devices
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Bathroom Safety Equipment
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Medical Furniture
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: ASSISTIVE DEVICES FOR VULNERABLE GROUPS MARKET, BY END-USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End-user
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Home Care
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ASSISTIVE DEVICES FOR VULNERABLE GROUPS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End-user
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Assistive Devices for Vulnerable Groups Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End-user
6.2.6. Canada Assistive Devices for Vulnerable Groups Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End-user
6.2.7. Mexico Assistive Devices for Vulnerable Groups Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End-user
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End-user
6.3.4. Market Size and Forecast, By Country
6.3.5. France Assistive Devices for Vulnerable Groups Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End-user
6.3.6. Germany Assistive Devices for Vulnerable Groups Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End-user
6.3.7. Italy Assistive Devices for Vulnerable Groups Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End-user
6.3.8. Spain Assistive Devices for Vulnerable Groups Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End-user
6.3.9. UK Assistive Devices for Vulnerable Groups Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End-user
6.3.10. Rest of Europe Assistive Devices for Vulnerable Groups Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End-user
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End-user
6.4.4. Market Size and Forecast, By Country
6.4.5. China Assistive Devices for Vulnerable Groups Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End-user
6.4.6. Japan Assistive Devices for Vulnerable Groups Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End-user
6.4.7. India Assistive Devices for Vulnerable Groups Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End-user
6.4.8. South Korea Assistive Devices for Vulnerable Groups Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End-user
6.4.9. Australia Assistive Devices for Vulnerable Groups Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End-user
6.4.10. Rest of Asia-Pacific Assistive Devices for Vulnerable Groups Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End-user
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End-user
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Assistive Devices for Vulnerable Groups Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End-user
6.5.6. South Africa Assistive Devices for Vulnerable Groups Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End-user
6.5.7. Saudi Arabia Assistive Devices for Vulnerable Groups Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End-user
6.5.8. Rest of LAMEA Assistive Devices for Vulnerable Groups Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End-user
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. GN Resound Group
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Starkey Hearing Technologies
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Siemens AG
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. William Demant Holding A/S
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Sonova Holding AG
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. AI Squared
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Invacare Corporation
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Drive Medical
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Nordic Capital (Sunrise Medical LLC)
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Pride Mobility Products Corporation.
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ASSISTIVE DEVICES FOR VULNERABLE GROUPS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Hearing Vision Aids
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Mobility Assistive Devices
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Bathroom Safety Equipment
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Medical Furniture
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: ASSISTIVE DEVICES FOR VULNERABLE GROUPS MARKET, BY END-USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End-user
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Home Care
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ASSISTIVE DEVICES FOR VULNERABLE GROUPS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End-user
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Assistive Devices for Vulnerable Groups Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End-user
6.2.6. Canada Assistive Devices for Vulnerable Groups Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End-user
6.2.7. Mexico Assistive Devices for Vulnerable Groups Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End-user
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End-user
6.3.4. Market Size and Forecast, By Country
6.3.5. France Assistive Devices for Vulnerable Groups Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End-user
6.3.6. Germany Assistive Devices for Vulnerable Groups Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End-user
6.3.7. Italy Assistive Devices for Vulnerable Groups Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End-user
6.3.8. Spain Assistive Devices for Vulnerable Groups Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End-user
6.3.9. UK Assistive Devices for Vulnerable Groups Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End-user
6.3.10. Rest of Europe Assistive Devices for Vulnerable Groups Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End-user
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End-user
6.4.4. Market Size and Forecast, By Country
6.4.5. China Assistive Devices for Vulnerable Groups Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End-user
6.4.6. Japan Assistive Devices for Vulnerable Groups Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End-user
6.4.7. India Assistive Devices for Vulnerable Groups Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End-user
6.4.8. South Korea Assistive Devices for Vulnerable Groups Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End-user
6.4.9. Australia Assistive Devices for Vulnerable Groups Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End-user
6.4.10. Rest of Asia-Pacific Assistive Devices for Vulnerable Groups Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End-user
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End-user
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Assistive Devices for Vulnerable Groups Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End-user
6.5.6. South Africa Assistive Devices for Vulnerable Groups Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End-user
6.5.7. Saudi Arabia Assistive Devices for Vulnerable Groups Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End-user
6.5.8. Rest of LAMEA Assistive Devices for Vulnerable Groups Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End-user
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. GN Resound Group
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Starkey Hearing Technologies
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Siemens AG
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. William Demant Holding A/S
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Sonova Holding AG
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. AI Squared
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Invacare Corporation
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Drive Medical
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Nordic Capital (Sunrise Medical LLC)
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Pride Mobility Products Corporation.
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
